Covid-19 Testing Still Critical To Curb Pandemic: EverlyWell CEO

Mar.29 -- Julia Cheek, founder and CEO of EverlyWell Inc, discusses the importance of maintaining a wide-scale Covid-19 testing level in the U.S. to contain and track the disease despite the ongoing mass vaccination efforts. The provider of home testing kits is said to be valued at $2.9 billion after making its first two acquisitions. Cheek speaks to Emily Chang on "Bloomberg Technology."